Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Interactive Journal of Medical Research

Date Submitted: Mar 4, 2024
Date Accepted: Oct 15, 2024

The final, peer-reviewed published version of this preprint can be found here:

Skeletal Muscle Mass Loss and Physical Function in Young to Middle-Aged Adult Patients With Diabetes: Cross-Sectional Observational Study

Naruse A, Yamada Y, Miyamoto T

Skeletal Muscle Mass Loss and Physical Function in Young to Middle-Aged Adult Patients With Diabetes: Cross-Sectional Observational Study

Interact J Med Res 2024;13:e58038

DOI: 10.2196/58038

PMID: 39693147

PMCID: 11694047

Skeletal muscle mass loss and physical function in young to middle-aged adult patients with diabetes: A cross-sectional observational study

  • Aki Naruse; 
  • Yuka Yamada; 
  • Takeshi Miyamoto

ABSTRACT

Background:

Recently, it has been reported that older adults with type 2 diabetes mellitus (T2DM) have lower skeletal muscle mass than healthy individuals do. Although skeletal muscle mass in older adults with diabetes is occasionally reported, similar reports on young to middle-aged adults are limited.

Objective:

To clarify the existence of skeletal muscle loss in young to middle-aged patients with diabetes and examine the relationship between skeletal muscle loss and physical function in these patients.

Methods:

This retrospective, observational study included patients aged ˂65 years with T2DM who were admitted to our hospital between 2015 and 2021for educational admission for glycemic control and requested rehabilitation by the Department of Metabolism. The main parameters included skeletal muscle mass, muscle strength, physical function, and activities of daily living.

Results:

In total, 15%–18% of young to middle-aged adults with diabetes had skeletal muscle index values below the Asian Working Group for Sarcopenia criteria for sarcopenia; however, compared with the non-diabetes group, a significant difference was observed in men but not in women (P<0.001 in the men, P=0.35 in the women). Nonetheless, the diabetes group exhibited significantly lower muscle strength and physical functions, such as a walking speed of 1.3 ± 0.2 m/s in men and 1.2 ± 0.43 m/s in women in the T2DM group and 1.6 ± 0.2 m/s and 1.5 ± 0.1 m/s for men and women in the control group, respectively. One-leg standing time was measured as 30.7 ± 26.9 s and 29.4 ± 25.5 s for men and women in the T2DM group, respectively. Univariate logistic regression analysis showed that skeletal muscle mass index (SMI) was significantly correlated with age, body mass index (BMI), and peripheral neuropathy. Multiple logistic regression analysis showed that BMI exhibited the strongest correlation (odds ratio 1.15, confidence interval 1.07–1.23, P<0.001). Peripheral neuropathy was also significantly correlated with SMI (P=0.009).

Conclusions:

Patients with diabetes, even those who are not older adults, face an elevated risk of muscle weakness and a decline in physical function; moreover, they are susceptible to dynapenia and presarcopenia. Therefore, early intervention focusing on muscle evaluation and exercise is crucial. Clinical Trial: Ethics No. 2366, September 13, 2021


 Citation

Please cite as:

Naruse A, Yamada Y, Miyamoto T

Skeletal Muscle Mass Loss and Physical Function in Young to Middle-Aged Adult Patients With Diabetes: Cross-Sectional Observational Study

Interact J Med Res 2024;13:e58038

DOI: 10.2196/58038

PMID: 39693147

PMCID: 11694047

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.